Thu. 09/27
Session T.6 / KMS Chamber musichall / 10.30 - 12.30 am
Apheresis in Cardiovascular Diseases II
Chairman 1: A. Vogt, Munich, Germany / Chairman 2: V. Schettler, Goettingen, Germany
| 10.30 - 11.00 am | K12 | Will new lipid lowering drugs make lipoprotein apheresis neglectable? Keynote: A. Vogt, Munich, Germany |
| 11.00 - 11.30 am | K13 | Lipoprotein(a) - more thromobogenic than atherogenic? BR Jaeger, Muehlheim, Germany |
| 11.30 - 12.00 am | K14 | Immunoadsorption in idiopathic dilated cardiomyopathy - Where do we stand? Keynote: L. Herda, Greifswald, Germany |
| 12.00 - 12.15 am | O33 | Efficacy of Plasma Exchange for Dilated Cardiomyopathy in Children (JSAO presentation) K. Matsuda |
| 12.15 - 12.30 am | O34 | Correlation of specific lipoprotein apheresis-induced changes of plasma lipidome with indicators of oxidative stress J. Graessler, Dresden, Germany |